Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological

Frontiers Cyclodextrins and Iatrogenic Hearing Loss: New Drugs with Significant Risk

IJMS, Free Full-Text

2-Hydroxypropyl-β-Cyclodextrin Raises Hearing Threshold in Normal Cats and in Cats With Niemann-Pick Type C Disease

Frontiers Pro-Inflammatory Implications of 2-Hydroxypropyl-β-cyclodextrin Treatment

2-Hydroxypropyl-β-cyclodextrin Ototoxicity in Adult Rats: Rapid Onset and Massive Destruction of Both Inner and Outer Hair Cells Above a Critical Dose

Pluronic based β-cyclodextrin polyrotaxanes for treatment of Niemann-Pick Type C disease

Hydroxypropyl-Beta-Cyclodextrin Reduces Inflammatory Signaling from Monocytes: Possible Implications for Suppression of HIV Chronic Immune Activation

Biomolecules, Free Full-Text

Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial. - Abstract - Europe PMC

2-Hydroxypropyl-β-Cyclodextrin Raises Hearing Threshold in Normal Cats and in Cats With Niemann-Pick Type C Disease

Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1–2 trial - The Lancet

Molecules, Free Full-Text

Cyclodextrin polymer improves atherosclerosis therapy and reduces ototoxicity - ScienceDirect

WO2017163128A2 - Use of cyclodextrins to reduce endocytosis in malignant and neurodegenerative disorders - Google Patents

Frontiers Pro-Inflammatory Implications of 2-Hydroxypropyl-β-cyclodextrin Treatment